LION Corporation announced that it will build a new pharmaceutical plant in Vietnam’s Hung Yen Province. The investment is approximately ¥1.5 billion, with construction scheduled to start in October 2026 and operations targeted to begin in the second half of 2030.
LION Corporation will build a new pharmaceutical plant in Vietnam’s Hung Yen Province through its wholly owned subsidiary メラップライオン. The site area will be 2,660 m² and the total floor area will be 7,172 m². The plant will focus on manufacturing solid dosage pharmaceuticals, including tablets and granules.
The investment is estimated at approximately VND 250 billion (approximately ¥1.5 billion), while specific figures for the future construction plan and capital investment are provided in the body of the report. Construction is scheduled to start in October 2026, with operations expected to begin in the second half of 2030. Products to be manufactured will include prescription drugs and OTC products.